ACDA (Terumo BCT Ltd)
Welcome to the PulseAid listing for the ACD drug offered from Terumo BCT Ltd. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Terumo BCT Ltd |
| NON-PROPRIETARY NAME: | Dextrose Monohydrate, Sodium Citrate, and Citric Acid Monohydrate |
| SUBSTANCE NAME: | DEXTROSE MONOHYDRATE; SODIUM CITRATE; CITRIC ACID MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2002-02-25 |
| END MARKETING DATE: | 0000-00-00 |
ACD A HUMAN PRESCRIPTION DRUG Details:
| Item Description | ACD A from Terumo BCT Ltd |
| LABELER NAME: | Terumo BCT Ltd |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.45; 2.2; .8(g/100mL; g/100mL; g/100mL) |
| START MARKETING DATE: | 2002-02-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 14537-967_66e7629c-27ad-4a39-982d-1c56e38156b6 |
| PRODUCT NDC: | 14537-967 |
| APPLICATION NUMBER: | BA010228 |
Other DEXTROSE MONOHYDRATE; SODIUM CITRATE; CITRIC ACID MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
